Christina (Tina) Lockwood, PhD, DABCC, DABMGG
Associate Professor, Department of Laboratory Medicine
Associate Director, Genetics and Solid Tumor Diagnostics Laboratory
University of Washington
Department of Laboratory Medicine, NW120
1959 Pacific St.
Seattle, WA 98195‑7110
Dr. Lockwood joined the Department of Laboratory Medicine as an Associate Director of the Genetics and Solid Tumor Diagnostics Laboratory at the University of Washington Medical Center in 2014. She is a Diplomate of the American Board of Clinical Chemistry and the American Board of Medical Genetics and Genomics. After obtaining her PhD at the University of Wisconsin, Dr. Lockwood completed postdoctoral fellowship training in Clinical Chemistry and Clinical Molecular Genetics at the Washington University School of Medicine in St. Louis, MO. Her interests include the development and application of molecular methods for the detection of genomic alterations in genetic disease, hematologic malignancies, and solid tumors. Dr. Lockwood has also been active in the design and implementation of educational resources related to training in genomic medicine.
Education and Training
- University of North Carolina at Chapel Hill: B.S. Biology, B.A. music, 1996‑2001
- University of Wisconsin, Madison, WI: Ph.D. Cellular and Molecular Biology, 2001‑2007
- Washington University School of Medicine, St. Louis, MO: Clinical Chemistry Fellowship, 2007‑2010
- Washington University School of Medicine, St. Louis, MO: Molecular Genetics Fellowship, 2012‑2014
- Molecular Pathology
- Molecular Genetics
- Clinical Chemistry
Clinical and Research Interests
- Precision medicine
- Genomic profiling of cancer
- Next‑generation sequencing
- Genetics of human disease
- Genomics education
- Member, Academy of Clinical Laboratory Physicians and Scientists
- Member, American Association for Clinical Chemistry
- Member, Association for Molecular Pathology
- Fellow, National Academy of Clinical Biochemistry
- Hagemann IS, Siddhartha D, Lockwood CM, et al. Clinical next‑generation sequencing in patients with non‑small cell lung cancer. Cancer. 2015; 38:534‑41.
- Abel HJ, Lockwood CM, Duncavage EJ, et al. Detection of gene rearrangements in targeted clinical next‑generation sequencing. J Mol Diagn. 2014; 16: 405‑17.
- Sehn JK, Hagemann IS, Pfeifer JD, Cottrell CE, Lockwood CM. Diagnostic utility of targeted next generation sequencing in problematic cases. Am J Surg Pathol. 2014; 38: 534‑41.
- Cottrell CE, Al‑Kateb H, Lockwood CM, et al. Validation of a next‑generation sequencing assay for clinical molecular oncology. J Mol Diagn. 2014; 16: 89‑105.
- Spencer DH, Abel HJ, Lockwood CM, et al. Detection of FLT3 internal tandem duplication in Illumina next generation sequencing data. J Mol Diagn. 2013; 15: 81‑93.
Honors and Awards
- AACC Outstanding Speaker Award, 2011‑2014
- AACC Annual Meeting Student Oral Presentation Award, 2010
- Best Poster Award (AACC, Pediatric Maternal‑Fetal Medicine), 2010
- Paul E. Strandjord Young Investigator Award, 2009, 2010
- AACC Annual Meeting Student Oral Presentation Award, 2009
- Richard Marshall Education Award, 2009
- John Jefferson Davis Award, 2006
- International C. elegans Annual Meeting Poster Award, 2003
- Phi Beta Kappa, 2001
Last updated: 07/12/2017